Document is current
Any future updates will be listed below
-
Authors
Bloom, Joshua http://orcid.org/0000-0001-7654-7828
Pantouris, Georgios
He, Mingzhu
Aljabari, Bayan
Mishra, Lopa
Manjula, Ramu
Parkins, Andrew
Lolis, Elias J.
Al-Abed, Yousef
-
Funding
Funding for this research was provided by:
Feinstein Institutes for Medical Research (N/A)
University of the Pacific (N/A)
- License Information
-
More Information
Article History
Received: 26 October 2023
Accepted: 26 February 2024
First Online: 27 March 2024
Declarations
:
: All animal experiments were performed in accordance to the National Institute of Health (NIH) guidelines and under protocols approved by the IACUC of the Feinstein Institute for Medical Research.
: Not applicable.
: JB and YA are co-holders of a patent for the use of T-614 as an inhibitor of MIF. YA is an inventor or co-inventor for multiple other small molecule inhibitors of MIF. MH, BA, and YA are current staff at the Feinstein Institutes for Medical Research. JB received a stipend as a MD/PhD candidate in the Zucker School of Medicine at Hofstra/Northwell Health, and his PhD studies were completed at the Feinstein Institutes for Medical Research. The authors have no other potential conflicts of interest to declare.
